Jackson P Tai - Director, Eli Lilly & Co

As of November 17, 2021


Jackson P Tai Net Worth

  • Net worth is estimated to be at least $28.75M
  • Owns at least 61,195 units of Eli Lilly & Co stock

Jackson P Tai Trading

  • Largest purchase of shares was 17,157 units , worth over $1.02M on May 13, 2014
  • In total has made about 50 transactions over 8 years
  • Usually trades in December, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Eli Lilly & Co Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Other Earnings Plans or Compensations
David A. Ricks 2020 $1,483,333 $0 $13,587,500 $0 $23,708,629 $5,883,924 $128,372 $23,708,629
David A. Ricks 2019 $1,400,000 $0 $12,222,000 $0 $21,283,242 $4,658,242 $84,000 $21,283,242
David A. Ricks 2018 $1,400,000 $0 $10,584,000 $0 $17,230,337 $1,529,337 $84,000 $17,230,337
Joshua L. Smiley 2020 $983,333 $0 $3,587,100 $0 $7,314,248* $2,685,276 $58,539 $7,314,248*
Joshua L. Smiley 2019 $895,833 $0 $3,142,800 $0 $7,348,401* $2,073,070 $53,750 $7,348,401*
Joshua L. Smiley 2018 $875,000 $0 $2,704,800 $0 $5,245,343 $174,980 $52,500 $5,245,343
Daniel M. Skovronsky, M.D., Ph.D. 2020 $983,333 $0 $4,456,700 $0 $7,352,112 $751,223 $58,539 $7,352,112
Daniel M. Skovronsky, M.D., Ph.D. 2019 $900,000 $0 $4,074,000 $0 $6,662,971 $446,521 $54,000 $6,662,971
Daniel M. Skovronsky, M.D., Ph.D. 2018 $837,500 $0 $2,806,000 $0 $5,145,898 $75,717 $50,250 $5,145,898
Anat Hakim 2020 $710,417 $150,000 $4,174,043 $0 $5,917,899 $87,848 $124,958 $5,917,899
Anat Hakim 2019 - - - - - - - -
Anat Hakim 2018 - - - - - - - -
Alfonso G. Zulueta 2020 $850,000 $0 $2,445,750 $0 $6,567,477 $2,268,269 $50,608 $6,567,477
Alfonso G. Zulueta 2019 - - - - - - - -
Alfonso G. Zulueta 2018 - - - - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000104/llydef14a2021.htm

Eli Lilly & Co Insider Trading

  • The most recent transaction was 195,000 units sold on November 5, 2021 by Lilly Endowment Inc worth over $52.42M
  • In the last 18 years, insiders at Eli Lilly & Co sold an estimated value of $4.63B and bought an estimated value of $410.87M
  • The most active traders are Lilly Endowment Inc,  Ralph Alvarez, Director,  and George M.C. Fisher Authorization On File, Director
  • Insider trading is most common in February, with the busiest year in 2006

ELI LILLY & Co Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1